New Pilot Program Will Mentor and Advance Women's Health
ORWH, in partnership with the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), is launching a pilot program, the Team Science Leadership Scholars Program (LSP). This program will support and train scholars by helping them acquire and hone team science leadership and mentoring skills. The LSP will develop a cohort of scientists who can lead complex, high-impact research programs in academia, industry, and the public health sector. It also aims to create a framework for teaching mid-career scientists the skills they need to be successful mentors. Learn more.
Read In The Spotlight Articles
NIH "All About Grants" Podcast on Sex as a Biological Variable
NIH expects that sex as a biological variable (SABV) will be factored into research designs, analyses, and reporting in preclinical and clinical studies. Accounting for SABV helps interpret and validate research findings, as well as enhancing the rigor, reproducibility, and applicability of biomedical research. But how exactly do you account for SABV? ORWH's Dr. Chyren Hunter explains. Listen to Podcast.
Request for Information on NIH-Wide Strategic Plan for Research on the Health of Women (NOT-OD-22-186) Input on the next strategic plan will be accepted through Thursday, September 29. All responses must be submitted electronically here. Send any inquiries to NIHWideSPWH@nih.gov.
Notice of Special Interest (NOSI): Increasing Uptake of Evidence-Based Screening in Diverse Populations Across the Lifespan (NOT-OD-22-178) Application due date: October 4, 2022
NOSI: Addressing Evidence Gaps in Screening (NOT-OD-22-179) Application due date: October 4, 2022
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) (PAR-22-105) Application due date: October 5, 2022
NOSI: Administrative Supplements for Research on Women’s Health in the IDeA States (NOT-GM-22-005) Application due date: October 17, 2022
Galvanizing Health Equity Through Novel and Diverse Educational Resources (GENDER) R25 (RFA-OD-22-015) Application due date: October 27, 2022
Maternal Health Research Centers of Excellence (U54 Clinical Trial Optional) (RFA-HD-23-035) Letter of Intent due date: November 2, 2022
|